| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.058 | 0.5 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.5 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |